Literature DB >> 23098781

Predictors of ischemia in patients referred for evaluation of exertional dyspnea: a stress echocardiography study.

Edgar Argulian1, Dan G Halpern, Vikram Agarwal, Shiv K Agarwal, Farooq A Chaudhry.   

Abstract

BACKGROUND: There are conflicting data on the incidence of ischemia by stress echocardiography in patients referred for dyspnea without accompanying chest pain.
METHODS: A total of 311 consecutive patients with exertional dyspnea (without chest pain) referred to the echocardiography lab for ischemia evaluation from August 2008 to March 2012 were evaluated. Exercise by Bruce protocol or dobutamine stress echocardiography was performed. Resting left ventricular ejection fraction and segmental wall motion abnormalities were assessed. Multivariate logistic regression analysis was used to identify independent predictors of ischemia on stress echocardiography.
RESULTS: The mean age was 61 years (range, 20-96 years), with 196 women (63%). Exercise stress was performed in 114 patients (37%); the rest of the patients underwent dobutamine stress. The patient population had a high burden of obesity, diastolic dysfunction, and pulmonary hypertension. Thirty patients (10%) had evidence of stress-induced ischemia (nine [8%] with exercise and 21 [11%] with dobutamine). In multivariate analysis, male gender (odds ratio, 2.8; P = .03), history of coronary artery disease (odds ratio, 3.5; P = .02), and resting wall motion abnormalities (odds ratio, 16.6; P < .01) were independent predictors of inducible ischemia.
CONCLUSIONS: The incidence of stress-induced ischemia is low in patients referred for stress echocardiography with exertional dyspnea (without chest pain). Ischemia is more likely to be present in men with histories of coronary artery disease and resting wall motion abnormalities.
Copyright © 2013 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23098781     DOI: 10.1016/j.echo.2012.09.012

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  7 in total

1.  Comparison of the current reasons for undergoing pharmacologic stress during echocardiographic and radionuclide stress testing.

Authors:  Edgar Argulian; Jose Ricardo F Po; Seth Uretsky; Kiran K Kommaraju; Suketukumar Patel; Vikram Agarwal; Randy Cohen; Alan Rozanski
Journal:  J Nucl Cardiol       Date:  2016-02-24       Impact factor: 5.952

2.  Evaluating left ventricular systolic dysfunction: Stress echocardiography.

Authors:  Edgar Argulian; Farooq A Chaudhry
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

Review 3.  Diastolic stress echocardiography.

Authors:  Tsutomu Takagi
Journal:  J Echocardiogr       Date:  2017-03-07

Review 4.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Authors:  Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge
Journal:  Circulation       Date:  2021-04-22       Impact factor: 29.690

5.  Stress-induced Worsening of Left Ventricular Diastolic Function as a Marker of Myocardial Ischemia.

Authors:  Mohamad Jihad Mansour; Wael Aljaroudi; Ali Mroueh; Omar Hamoui; Walid Honeine; Nada Khoury; Jinane Abi Nassif; Elie Chammas
Journal:  J Cardiovasc Echogr       Date:  2017 Apr-Jun

6.  Stress echocardiography in coronary artery disease: a practical guideline from the British Society of Echocardiography.

Authors:  Richard P Steeds; Richard Wheeler; Sanjeev Bhattacharyya; Joseph Reiken; Petros Nihoyannopoulos; Roxy Senior; Mark J Monaghan; Vishal Sharma
Journal:  Echo Res Pract       Date:  2019-06-01

Review 7.  Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.

Authors:  Rohan Samson; Abhishek Jaiswal; Pierre V Ennezat; Mark Cassidy; Thierry H Le Jemtel
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.